Table 4.
Clinical outcomes in surviving and non-surviving patients with CAP.
| Variable | Surviving (n = 24) | Non-surviving (n = 11) |
|---|---|---|
| Age, years (mean±SD) | 54.1±8.7 | 70.6±3.6* |
| Sex, male:female | 15:9 | 7:4 |
| Antibiotics received before treatment, n (%) | 13 (54.2) | 5 (45.5) |
| Symptoms, n (%) | ||
| Fever | 12 (50.0) | 6 (54.5) |
| Cough | 10 (41.7) | 5 (41.7) |
| Sputum | 8 (33.3) | 4 (36.4) |
| Shortness of breath | 5 (20.8) | 3 (27.3) |
| Chest pain | 5 (20.8) | 2 (18.2) |
| Laboratory | ||
| CRP, mg/L | 72 (23–125) | 169 (117–229)* |
| WBC, 109/mL | 8.4 (7.5–11.6) | 14.5 (11.2–16.9)* |
| Cortisol, nmol/L | 545 (295–909) | 1123 (558–1309)* |
| HMGB-1, ng/mL | 58.5 (31–105) | 138 (88–151)* |
| PSI, n (%) | ||
| I–III | 15 (62.5) | 4 (36.4)* |
| IV–V | 9 (37.5) | 7 (63.6)* |
CAP: community-acquired pneumonia, SD: standard deviation, WBC: white blood cell count, CRP: C-reactive protein, HMGB-1: high mobility group box-1 protein, PSI: pneumonia severity index. *P < 0.05, compared with surviving group.